Mesoblast Limited (MESO) Balance Sheet

NASDAQ: MESOAssets, liabilities, debt and equity over 10 years.

MESO balance sheet, FY2026

June 30, 2026 · U.S. dollars

$773.1M assets = $204.7M liabilities + $568.4M equity

What it owns$773.1MCash & ST investments: $47.4M (6.1%)$47.4MReceivables: $57.7M (7.5%)Receivables $57.7MInventory: $28.1M (3.6%)Other current: $64.3M (8.3%)Other current $64.3MPP&E: $8.0M (1.0%)Goodwill & intangibles: $566.4M (73.3%)Goodwill & intangibles$566.4M · 73%Other non-current: $1.2M (0.2%)=How it is financed$773.1MCurrent liabilities: $81.1M (10.5%)Current liabilities $81.1MLong-term debt: $108.6M (14.1%)Long-term debt$108.6M · 14%Other LT liabilities: $14.9M (1.9%)Shareholders’ equity: $568.4M (73.5%)Shareholders’ equity$568.4M · 74%

Both columns are drawn to the same scale: what MESO owns equals what it owes plus shareholders’ equity. Hover a block for its value.

MESO financial health

Current ratio2.43
Comfortable · current assets cover current liabilities 2.43×
Debt / equity0.22
Low leverage · $0.22 of debt for each $1 of equity
Equity / assets73.5%
Equity-funded · of assets funded by shareholders
Cash / debt37.2%
Low cash cover · cash & short-term investments vs total debt
Goodwill & intangibles73.3%
Mostly intangible · of total assets

Descriptive bands, not a rating. Fiscal FY2026.

MESO balance sheet trends, FY2017–FY2026

Mesoblast Limited balance sheet trends
MetricTrendThenLatestChange
Total assets$655.7MFY2017$773.1MFY2026+1.8%/yr
Total liabilities$138.9MFY2017$204.7MFY2026+4.4%/yr
Shareholders’ equity$516.8MFY2017$568.4MFY2026+1.1%/yr
Cash & short-term investments$45.8MFY2017$47.4MFY2026+0.4%/yr
Total debt$59.4MFY2018$127.3MFY2026+10.0%/yr
Net cash (debt)−$21.6MFY2018−$79.9MFY2026−$58.3M
Working capital$26.9MFY2017$116.4MFY2026+$89.4M
Book value per share$9.61FY2017$4.39FY2026−8.3%/yr
Current ratio1.73FY20172.43FY2026+0.70
Debt / equity0.11FY20180.22FY2026+0.12
Shares outstanding53.8MFY2017129.5MFY2026+10.3%/yr

Change is the average annual growth (CAGR) or the difference between the first and latest year.

MESO assets

Cash & ST investmentsReceivablesInventoryOther currentPP&EGoodwill & intangiblesLT investmentsOther non-current

MESO liabilities and equity

Current liabilitiesLong-term debtOther long-term liabilitiesEquity

MESO debt vs cash

Total debtCash & ST investmentsNet cash (debt)

Debt includes short- and long-term borrowings and, where reported, lease obligations.

MESO balance sheet

Mesoblast Limited annual balance sheet
FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Assets
Cash & short-term investments$47.4M$161.2M$62.6M$70.9M$60.0M$136.9M$129.3M$50.4M$37.8M$45.8M
Cash & equivalents$47.4M$161.2M$62.6M$70.9M$60.0M$136.9M$129.3M$50.4M$37.8M$45.8M
Receivables$57.7M$14.9M$21.0M$7.0M$4.4M$4.6M$1.3M$1.7M$50.4M$1.3M
Inventory$28.1M$22.2M$0−$4.3M$0−$252,000−$252,000−$250,000−$250,000$13.9M
Other current assets$64.3M$6.1M$2.9M$8.1M$5.4M$7.0M$6.2M$10.6M$13.2M$2.7M
Total current assets$197.5M$204.3M$86.5M$81.7M$69.8M$148.2M$136.5M$62.5M$101.1M$63.6M
Property, plant & equipment (net)$8.0M$5.8M$3.8M$6.5M$10.0M$12.1M$10.3M$826,000$1.1M$1.8M
Goodwill & intangible assets$566.4M$571.8M$575.7M$577.2M$578.7M$580.5M$581.6M$583.1M$584.6M$586.4M
Long-term investments$0$1.4M$1.0M$1.8M$1.8M$2.1M$1.9M$2.3M$2.3M$2.0M
Other non-current assets$1.2M$1.3M$2.1M$2.3M$1.9M$1.7M$3.3M$3.3M$3.4M$1.9M
Total assets$773.1M$784.7M$669.2M$669.4M$662.1M$744.7M$733.6M$652.1M$692.4M$655.7M
Liabilities
Accounts payable$34.5M$19.1M$7.1M$20.1M$23.1M$19.6M$25.0M$13.1M$18.9M$21.8M
Short-term debt$13.6M$56.8M$16.5M$10.0M$8.2M$56.0M$36.0M$14.0M$59.4M—
Deferred revenue———$6.4M$17.9M−$56.0M−$36.0M−$14.0M——
Total current liabilities$81.1M$102.6M$73.2M$42.0M$51.4M$94.3M$90.1M$44.3M$24.0M$36.7M
Long-term debt$108.6M$67.7M$100.5M$102.8M$91.6M$41.0M$57.0M$67.3M$59.4M$0
Lease obligations$8.1M$6.3M$4.6M$7.7M$10.3M$11.2M$9.8M———
Other long-term liabilities$14.9M$16.9M$15.1M$22.8M$22.1M$28.0M$37.1M$59.5M$63.0M$102.2M
Total liabilities$204.7M$187.2M$188.8M$167.6M$165.1M$163.3M$184.3M$171.1M$146.4M$138.9M
Shareholders' equity
Common stock & paid-in capital$1.53B$1.51B$1.31B$1.25B$1.17B$1.16B$1.05B$910.4M$889.5M$830.4M
Retained earnings (deficit)−$1.07B−$1.01B−$908.8M−$820.8M−$738.9M−$647.6M−$548.8M−$470.0M−$380.2M−$344.9M
Accumulated other comprehensive income$106.0M$99.5M$78.3M$73.5M$70.7M$65.8M$46.6M$40.6M$36.7M$31.2M
Total shareholders' equity$568.4M$597.4M$480.4M$501.8M$497.0M$581.4M$549.3M$481.1M$546.0M$516.8M
Key figures
Total debt$127.3M$128.2M$118.9M$116.5M$106.9M$105.5M$99.3M$81.3M$59.4M—
Net cash (debt)−$79.9M$33.0M−$56.4M−$45.6M−$46.9M$31.4M$30.0M−$30.9M−$21.6M—
Working capital$116.4M$101.7M$13.2M$39.7M$18.5M$54.0M$46.4M$18.2M$77.1M$26.9M
Tangible book value$2.0M$25.6M−$95.4M−$75.3M−$81.6M$851,000−$32.3M−$102.1M−$38.6M−$69.6M
Book value per share$4.39$4.95$4.87$5.98$7.28$9.61$10.39$9.73$5.86$9.61
Shares outstanding129.5M120.8M98.7M83.9M68.3M60.5M52.9M49.4M93.1M53.8M
Current ratio2.431.991.181.951.361.571.511.414.211.73
Quick ratio1.301.721.141.861.251.501.451.183.671.28
Debt / equity0.220.210.250.230.220.180.180.170.11—
Equity / assets73.5%76.1%71.8%75.0%75.1%78.1%74.9%73.8%78.9%78.8%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed August 27, 2026); data from EODHD.

MESO financial position

At the end of fiscal 2026 (June 30, 2026), Mesoblast had total assets of $773.1 million (down 1.5% from a year earlier), total liabilities of $204.7 million and shareholders' equity of $568.4 million. It held $47.4 million in cash and short-term investments against $127.3 million of debt, net debt of $79.9 million. Its current ratio was 2.43.

Related: MESO income statement, MESO cash flow statement, MESO key metrics. See the MESO stock overview for the latest quote and news.

MESO balance sheet FAQ

What are Mesoblast's total assets?

Mesoblast reported total assets of $773.1 million at the end of fiscal 2026 (June 30, 2026), compared with $784.7 million a year earlier.

How much debt does Mesoblast have?

Mesoblast had $127.3 million of total debt at the end of fiscal 2026, including short-term borrowings and lease obligations. Its debt-to-equity ratio was 0.22.

How much cash does Mesoblast have?

Mesoblast held $47.4 million in cash and short-term investments at the end of fiscal 2026; with $127.3 million of debt that is net debt of $79.9 million.

What is Mesoblast's book value?

Mesoblast's shareholders' equity (book value) was $568.4 million at the end of fiscal 2026, or $4.39 per share.

What is Mesoblast's current ratio?

Mesoblast had current assets of $197.5 million and current liabilities of $81.1 million, a current ratio of 2.43 (it can cover its short-term obligations).

How much goodwill does Mesoblast have?

Mesoblast carried $566.4 million of goodwill and intangible assets, 73.3% of total assets, at the end of fiscal 2026.

Biotechnology: balance sheet